Ductal carcinoma in situ: risk factors and impact of screening.
about
Cytochrome c1 in ductal carcinoma in situ of breast associated with proliferation and comedo necrosis.Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment use.Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer.RNA-Seq of human breast ductal carcinoma in situ models reveals aldehyde dehydrogenase isoform 5A1 as a novel potential target.MTA1--a stress response protein: a master regulator of gene expression and cancer cell behavior.Treatment patterns for ductal carcinoma in situ from 2000-2010 across six integrated health plansLogical Differential Prediction Bayes Net, improving breast cancer diagnosis for older womenObesity and future prostate cancer risk among men after an initial benign biopsy of the prostate.Overdiagnosis among women attending a population-based mammography screening program.Family history and risk of ductal carcinoma in situ and triple negative breast cancer in a Han Chinese population: a case-control study.The impact of surgery, radiation, and systemic treatment on outcomes in patients with ductal carcinoma in situ.Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.Breast conserving therapy for DCIS--does size matter?Current management of lesions associated with an increased risk of breast cancer.Ductal carcinoma in situ - update on risk assessment and management.Addressing overtreatment in breast cancer: The doctors' dilemma.Predicting and Overcoming Chemotherapeutic Resistance in Breast Cancer.Associations Between Sentinel Lymph Node Biopsy and Complications for Patients with Ductal Carcinoma In Situ.Epidemiologic Risk Factors for In Situ and Invasive Breast Cancers Among Postmenopausal Women in the National Institutes of Health-AARP Diet and Health Study.Impact of hormone replacement therapy use on mammographic screening outcomes
P2860
Q33873665-1E9B4FF1-FC23-4C97-98B1-AE09F55B6F61Q34145175-62F83330-8438-4D1F-AB03-EE97EF3C8F25Q34315003-10052F0D-53A4-44F7-856E-93B1569C088BQ34510318-885B0DA9-43F0-4DF5-8B5B-A5CF75B53F8AQ34573808-0C18E3E9-4B1B-4533-B020-8B7174AFC8D2Q34989912-2F84B5DF-5826-491D-A92C-869A30441369Q36519171-C0B705FD-EFBD-46F8-9A46-453571051AAEQ36968554-8E5804D0-3189-4506-872A-C5C8C73409E3Q37001743-C7C3609B-670C-472D-BDA7-3BFEA668BB54Q37363424-DC017E13-8A48-4222-9DE0-84E7B557AB8DQ37509565-81DB0183-B872-4EE6-9E35-675B814FC53BQ37843725-2DF16ADD-2863-45AF-AC9A-ACA809F61EE4Q38214868-420E36AF-00D2-47A7-BFB5-ED4EA3603AA3Q38333149-5BB1AB3A-90E0-4504-8FEA-55EAF08464B2Q38696796-25BFCCF7-6042-4F97-A7A9-32685B5B5BBFQ47993032-17F61934-E1EF-4690-999C-98FFC618EE22Q49544395-D628E8C1-0903-47A5-B187-ABDD4E112548Q52667670-14922D0F-6792-446B-AEA1-7BFA26806188Q52858144-58CD2372-A4FB-4D23-BA27-B31CA755EC36Q57586245-940FF159-AE47-4C6F-B783-0349337947C8
P2860
Ductal carcinoma in situ: risk factors and impact of screening.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ductal carcinoma in situ: risk factors and impact of screening.
@en
Ductal carcinoma in situ: risk factors and impact of screening.
@nl
type
label
Ductal carcinoma in situ: risk factors and impact of screening.
@en
Ductal carcinoma in situ: risk factors and impact of screening.
@nl
prefLabel
Ductal carcinoma in situ: risk factors and impact of screening.
@en
Ductal carcinoma in situ: risk factors and impact of screening.
@nl
P2093
P2860
P356
P1476
Ductal carcinoma in situ: risk factors and impact of screening
@en
P2093
Beth A Virnig
Robert L Kane
Tatyana Shamilyan
Todd M Tuttle
P2860
P304
P356
10.1093/JNCIMONOGRAPHS/LGQ024
P50
P577
2010-01-01T00:00:00Z